Back to Blog
solar design18 min read

Solar Design for Pharma Plants: Cleanroom Loads

Solar design for pharmaceutical facilities: size arrays around cleanroom HVAC baseload, protect power quality, and keep GMP change control in order.

Nirav Dhanani

Written by

Nirav Dhanani

Co-Founder · SurgePV

Rainer Neumann

Edited by

Rainer Neumann

Editorial contributor · SurgePV

Published ·Updated

Answer

Solar design for pharmaceutical facilities starts with the cleanroom HVAC load curve, not the roof area. HVAC is around 65 percent of energy use in the industry per a 2008 EPA ENERGY STAR guide. Size the array for high on-site use, get harmonic data from the inverter datasheet, and run electrical changes through GMP change control.

Last updated: November 2026

A pharmaceutical manufacturing plant is an energy-intensive building, and most of that energy goes to air handling. Like factory solar system design and hospital solar system design, pharmaceutical solar must be sized around a critical process load rather than a generic commercial template. A 2008 LBNL guide for EPA ENERGY STAR estimated that HVAC components account for around 65 percent of the electricity and fuel used in the pharmaceutical industry, because cleanrooms need continuous filtered, conditioned and pressurized air. That makes solar design for pharmaceutical facilities a distinct discipline: the array is sized to a round-the-clock process load, and it must never destabilize a validated manufacturing environment.

The goal is not simply to cover annual consumption. It is to match a continuous cleanroom baseload, manage demand charges, preserve GMP compliance, and fit the array onto a roof that may sit above production space. This guide walks through the design workflow for oral solid dose, sterile injectable, biologics and API facilities. It covers load profiling, sizing, mounting, power quality, storage, resilience, finance and the mistakes that waste budget or trigger audit findings.

If you are designing pharmaceutical solar at scale, use a cloud solar design platform that imports interval data, runs shading analysis software and exports permit-ready plans. SurgePV provides this through its generation and financial tool, which models HVAC-specific tariffs, demand charges and cash-flow structures in one place.

Size solar around a cleanroom baseload

Import interval data and test array and battery scenarios against demand charges before you finalize a kWp number.

Book a Demo

Checking cost first? See the SurgePV pricing page · 20 minutes · Live project walkthrough

In this guide:

  • Why pharmaceutical solar design is a distinct discipline
  • How to profile cleanroom HVAC and process load
  • Rooftop, carport and ground-mount tradeoffs for pharma
  • Power quality, harmonic limits and GMP compliance
  • Battery storage sizing for peak shaving and resilience
  • Financial models and incentives for 2026
  • Common design mistakes and how to avoid them
  • Worked example for a 50,000 sq ft oral solid dose facility
  • FAQ with 7 pharmaceutical solar questions

Why Pharmaceutical Solar Design Is Different

A pharmaceutical facility is not a standard factory with extra air conditioning. It is a validated environment where temperature, humidity, pressure differential and particle count must stay inside tight bands around the clock. HVAC systems run continuously to protect product quality, and any electrical change that could introduce harmonics, voltage sags or downtime must pass GMP change control.

Three structural differences matter most:

  1. HVAC dominates energy use. Cleanroom Technology states that HVAC accounts for 50 to 80 percent of site energy in the pharmaceutical, life science and hi-tech sectors. Trotek Controlled Environments says a typical ISO 7 pharmaceutical cleanroom in Australia consumes 1,500 to 2,500 kWh per square metre per year, with HVAC at roughly 60 to 70 percent of that.
  2. Air-change rates drive load shape. Higher cleanroom grades need more air changes per hour, and the required rates depend on the classification and the governing guidance, so check the applicable GMP and ISO cleanroom standards for your rooms. The resulting fan and chiller load creates a steady daytime baseload that suits solar, plus a night baseload that solar cannot cover.
  3. Power quality is a GMP issue. Variable-frequency drives on cleanroom air handlers and chillers can be sensitive to harmonic distortion. Inverter harmonics can interfere with lab instruments, HVAC controls and process equipment, which creates a validation risk to manage.
Factor Standard factory Pharmaceutical facility
Largest energy use Process and motors HVAC (about 65% industry-wide per LBNL/EPA; 50 to 80% at some sites)
Air handling General ventilation Continuous filtered, pressurized, conditioned air
Uptime requirement Business critical GMP and batch critical
Electrical change control Standard project GMP change-control register
Roof structural concern Standard live load Cleanroom membrane and air-tightness
~65%
HVAC share of pharma energy use (LBNL for EPA ENERGY STAR, 2008)
50 to 80%
HVAC share of site energy at pharma and life science sites (Cleanroom Technology)
1,500 to 2,500
kWh per m² per year, typical ISO 7 pharma cleanroom, Australia (Trotek)

Key Takeaway

The published shares and intensities differ by source, scope and country. Use them to frame the conversation, then replace them with the plant’s own interval data before sizing anything.

The table explains why a proposal built on generic commercial assumptions will underperform or create compliance risk. Pharmaceutical solar design must treat the cleanroom HVAC system as the customer, not the roof.


Cleanroom HVAC and Process Load Profile

The first step in any pharmaceutical solar design is to understand where the kilowatt-hours go. The load profile sets the array size, the battery duration, the inverter rating and the financial case.

HVAC dominates consumption

HVAC is the largest single load in a pharmaceutical facility. It supplies filtered, conditioned air to cleanrooms, maintains pressure cascades, removes process heat, and controls humidity. In the U.S. pharmaceutical industry as a whole, the LBNL guide for EPA ENERGY STAR estimates HVAC at around 65 percent of energy use. Individual sites differ with process intensity and climate.

The load is not perfectly constant. It rises with ambient temperature, during batch start-up, when autoclaves or sterilisers add heat, and when production shifts change. In hot climates the load rises in summer, which tends to line up with solar output, but the size of that swing is site specific.

Process equipment adds daytime peaks

Manufacturing equipment such as granulators, tablet presses, coaters and packaging lines typically run two or three shifts. Water purification systems, compressed air plants and effluent treatment pumps often run 24 hours. The result is a high daytime baseload with process-specific peaks. Cleanrooms themselves stay online around the clock, so the night load never drops to zero.

Demand charges and time-of-use rates

Many pharmaceutical facilities pay demand charges based on the highest 15- or 30-minute power draw in each billing period. The rate is set by your tariff. Because HVAC load peaks on hot summer afternoons, solar generation often coincides with the facility’s highest draw. That coincidence is valuable. It means solar can reduce both energy charges and demand charges if the array is sized and dispatched correctly.

The generation and financial tool models time-of-use rates and demand charges hour by hour, so you can see whether solar alone delivers the expected savings or whether a battery is needed to shave the evening peak.


Sizing the Solar Array for a Pharmaceutical Facility

The correct sizing sequence for pharmaceutical solar is: measure load, model production, maximise self-consumption, then pick the kWp number. Residential rules of thumb will mislead you.

Step 1: Collect interval data and building information

Request 12 to 24 months of 15-minute or 30-minute interval data from the utility. Monthly bills hide the daily peaks and the seasonal shape. You also need:

  • Gross floor area and clear ceiling height
  • Cleanroom grades and air-change rates
  • Year of construction and roof age
  • HVAC system type, chiller capacity and age
  • Demand charge structure and time-of-use windows
  • Plans for expansion, additional production lines or electrification

Step 2: Separate HVAC baseload from process peaks

Build a load curve by month and by hour. An oral solid dose facility in the southern United States might show an HVAC baseload of 400 kW in January and peaks of 700 kW in July. A sterile fill-finish suite might see larger daily swings as autoclaves and isolators cycle. The summer peak drives the inverter and interconnection sizing, while the annual kWh drives the array size.

Step 3: Choose a target offset based on self-consumption

A steady cleanroom baseload means a large share of solar output can be used on site, and storage raises it further, but the real ratio comes from hourly simulation. Because exported solar is usually worth less than on-site consumption, the economic optimum is often an array that covers well under 100 percent of annual load.

Run three sizing scenarios. The percentages are starting points to test, not standards:

Scenario Sizing target Best for
High self-consumption Production = 30 to 50% of annual load Strong net metering or net billing with low export value
Maximum roof use Production = 60 to 80% of annual load Favourable feed-in tariff or large daytime baseload
Export-limited Production = on-site minimum daytime load Strict interconnection or net metering caps

Step 4: Convert target kWh to DC capacity

Divide the target annual kilowatt-hours by the local capacity factor. Capacity factor depends on location, tilt, azimuth and losses. As one data point, the NLR PVWatts v8 API (run 4 November 2026) gives about 15.7 percent on an AC basis for a south-facing, 10 degree flat-roof array in Houston with default 14 percent losses. Run PVWatts or your design software for your own site.

For example, a facility targeting 1,050,000 kWh/year of solar generation at a 15.7 percent capacity factor needs:

  • Required DC capacity = 1,050,000 kWh/year ÷ (0.157 × 8,760 hours) = about 763 kWp

Round to a practical module layout. A 750 kWdc system gives about 1,034,600 kWh/year in the PVWatts run above.

Step 5: Add storage if the peak matters

If the facility pays high demand charges or faces time-of-use rates with steep evening peaks, add a battery energy storage system. The battery captures midday solar surplus and discharges during the peak window. Many designers start with a 2 to 4 hour battery sized at a fraction of peak facility demand, then adjust after simulation.

Use solar design software with interval-data import to test these scenarios automatically. Manual spreadsheets struggle to capture the hourly value of self-consumption, export and demand-charge savings at the same time.


Mounting Options: Rooftop, Carport, Ground-Mount

Most pharmaceutical facilities have three real-estate options. Each has a different cost, risk profile and operational payoff.

Rooftop solar

Rooftop is usually the lowest-cost option and the most common for pharmaceutical plants. Large flat roofs, minimal obstructions and electrical rooms close to the array reduce balance-of-system costs. How much the roof can hold depends on usable area, setbacks and structural reserve capacity, so get a layout and a structural letter before quoting a size.

Pros:

  • Lowest installed cost per watt
  • No new land use
  • Fastest interconnection path
  • Production aligns with daytime HVAC load

Cons:

  • Limited by roof age and structural capacity
  • Fire setbacks and obstructions reduce usable roof area
  • HVAC equipment, exhaust stacks and parapets create exclusions
  • Re-roofing later requires panel removal and reinstallation

Over GMP cleanroom roofs, use non-penetrating ballasted mounting to preserve membrane integrity and air-tightness. Penetration-based mounts can void roof warranties and compromise the cleanroom envelope. Before committing to rooftop, get a structural letter. If the roof is near the end of its life, bundle the solar with a re-roof or move to a carport.

Solar carports

Carports cost more per watt than rooftop, but they solve several pharmaceutical problems at once. They provide shaded parking for staff and visitors, protect temperature-sensitive deliveries, avoid roof warranty conflicts and create a natural home for EV charging.

Pros:

  • Use parking-lot real estate the facility already owns
  • Provide shade for temperature-sensitive vehicles
  • Easy to pair with EV charging stubs
  • No roof structural limits

Cons:

  • Higher cost per watt due to steel structure
  • Foundation and civil work
  • May require stormwater review
  • Shorter experience base for some installers

Capacity depends on bay spacing and column layout. For facilities where the roof is old or small, carports often carry the project.

Ground-mount solar

Ground-mount works for pharmaceutical campuses with spare land, often near detention basins or unused acreage. It offers the lowest cost per watt and the easiest operations and maintenance access, but it competes with land use and requires fencing.

Pros:

  • Largest potential capacity per site
  • Optimal tilt and azimuth
  • Simple O&M access
  • Can use bifacial modules and tracking

Cons:

  • Land opportunity cost
  • Longer permitting and environmental review
  • Fencing, landscaping and security
  • Higher civil and interconnection cost

Land needed per megawatt depends on module efficiency, tilt and row spacing, so ask your designer for a layout.

Mounting option Cost trend Best for
Rooftop Lowest Strong roof, limited land
Carport Higher Old roof, shaded parking, EV charging
Ground-mount Low per watt Campus with spare land

Use shading analysis to check parapets, HVAC equipment and neighbouring buildings before finalising the rooftop layout. A small shadow on a string of modules can disproportionately reduce production if the stringing design is not planned around it.

For complex commercial projects that need detailed engineering support, permit packages or stamped electrical drawings, engineering consultancies such as Heaven Designs list solar design, detailed engineering and permit-ready packages for EPCs that need extra capacity.


Power Quality, Backup and GMP Compliance

Solar design for pharmaceutical facilities is not only about kilowatt-hours. It is also about how the array integrates with the HVAC plant, the electrical distribution and the validated state of the facility.

Specify low total harmonic distortion

Cleanroom air handlers, chillers and quality-control instruments are sensitive to harmonic distortion. Harmonic distortion can cause VFD trips, inaccurate readings on analytical equipment and bearing currents in motors. Ask the inverter manufacturer for harmonic data in its datasheet, check the harmonic limits in the applicable interconnection standard (such as IEEE 1547) and your utility requirements, and set acceptance limits with the plant’s electrical engineer. Run a pre- and post-commissioning power-quality study and append the report to the GMP electrical validation file.

Do not treat the battery as a full backup generator

A 4-hour battery cannot carry a Grade A suite through a multi-day outage. It is an energy-shifting and grid-support asset. Most pharmaceutical facilities still need diesel or natural-gas generators for extended outages and GMP-mandated redundancy. The battery reduces generator runtime and fuel consumption during short outages and provides smooth transition.

Coordinate with HVAC and building management systems

Solar inverters must be coordinated with the facility’s transfer switches, static switches and generator synchronisation. A grid-tied array without a microgrid controller will shut down during a utility outage to protect line workers. If the facility needs solar to operate off-grid, add a microgrid controller and design the system for islanding. For most facilities, the simpler path is to keep solar on the normal power system and leave the essential electrical system unchanged.

Document every change in the GMP register

Any electrical change at a GMP facility must be recorded in the change-control register. The solar project must produce updated single-line diagrams, updated emergency power load studies where applicable, commissioning reports, factory acceptance test and site acceptance test records, and staff training records. Auditors will not approve the solar system, but they will expect the facility to demonstrate that the change did not compromise validated state.

Plan for electrification loads

Pharmaceutical facilities are adding electric vehicles, heat pumps and additional production capacity. These loads increase electricity use and can shift the peak. Design the service entrance, transformer and solar inverter capacity with headroom for future electrification. Upgrading a service after construction usually costs more than sizing it correctly the first time.


Battery Storage and Peak Shaving

Battery storage has become a standard companion to pharmaceutical solar. It solves three problems that solar alone cannot: time-shifting, demand-charge reduction and short-duration resilience.

Time-shift surplus into evening peaks

A pharmaceutical facility consumes power after sunset. A battery captures the midday solar surplus and discharges from 5 PM to 9 PM, when the facility is still fully loaded but solar output has fallen. Size the battery from the hourly load curve rather than from a rule of thumb.

Reduce demand charges

Many facilities see a demand peak in late afternoon as solar fades but HVAC load remains high. A battery discharged during that window can reduce the monthly peak demand charge. As arithmetic, at an assumed $15 per kW per month, reliably shaving 300 kW for 12 months saves $54,000 a year. Check your tariff and interval data before counting on that.

Bridge short outages

The battery can keep critical HVAC controls and selected production equipment online during brief grid outages. It does not replace a diesel generator for a multi-day failure, but it can ride through the seconds to minutes needed for a generator to start or avoid a brief outage altogether.

A starting point, not a rule

Many grid-tied designs start with a 2 to 4 hour battery and adjust after simulation. The right ratio depends on the tariff structure, export limits and whether the operator values resilience or bill savings more. NLR’s cost benchmark report found that installed cost for commercial PV-plus-storage systems fell 8% from 2020 to 2024, so re-check any older battery quote. The business case usually rests on several value streams: demand-charge reduction, time-shifting and backup.

Pro Tip

Ask the plant’s electrical engineer to mark which circuits are on the essential system today. Keep solar on the normal power system and leave the essential system unchanged unless an islanding study says otherwise, since that avoids revalidating critical circuits.


Financial Model and Incentives for 2026

A large, continuous load helps solar economics, but the result still depends on ownership structure, incentives and local utility rates.

Installed costs

The National Laboratory of the Rockies (NLR, formerly NREL) report Documenting 15 Years of Reductions in U.S. Solar Photovoltaic System Costs (January 2025) benchmarks commercial PV at $1.55 per Wdc in Q1 2024, in 2024 dollars, for a 3-MWdc ground-mount system. A pharmaceutical rooftop will differ because of structural reviews, membrane warranty coordination, harmonic and power-quality studies and GMP documentation. For a deeper cost breakdown, see the solar installation cost breakdown. For ownership models, the commercial solar overview covers the same decision framework, and solar ROI for a pharmaceutical facility goes deeper on returns.

Ownership versus third-party finance

Direct ownership captures the full value of energy savings, incentives and depreciation. A taxable owner may use the federal credit and depreciation, subject to eligibility. A third-party power purchase agreement or lease offers zero upfront cost and predictable operating expenses, but passes some value to the financier.

Federal and state incentives

The IRS clean electricity investment credit page describes a 6% base rate that is increased five times, up to 30%, for facilities meeting prevailing wage and registered apprenticeship requirements. IRS Notice 2025-42 explains that, under Public Law 119-21, the credit terminates for applicable solar facilities placed in service after December 31, 2027, and that this applies to facilities whose construction begins after July 4, 2026.

Incentive Status What the source says
Clean electricity investment credit Active with solar deadlines Up to 30% with prevailing wage and apprenticeship compliance (IRS); cutoff for solar placed in service after Dec 31, 2027 unless construction began by July 4, 2026 (Notice 2025-42)
Bonus adders Eligibility specific Confirm domestic content and energy community eligibility with a tax adviser
Depreciation Rules changed in 2025 Use a tax adviser’s current schedule
State and utility programs Vary Check DSIRE

International context: India example

In India’s Baddi-Barotiwala-Nalagarh pharmaceutical cluster, a 1 MWp rooftop solar plant costs roughly ₹3.5 to 4 crore installed and generates 14.5 to 15.8 lakh kWh per year, according to Heaven Green Energy’s Baddi pharma solar guide (2026). The same page models 40 percent first-year accelerated depreciation and states a post-depreciation payback of roughly 4 to 5 years (its own text gives both 4 to 4.5 and 4.5 to 5). That page is published by Heaven Green Energy, the author’s employer, and it rests on its own tariff and tax assumptions, so treat it as one example rather than a benchmark.

Payback and long-term savings

Payback depends entirely on the tariff, the self-consumption share and the incentives the owner can use. The worked example below shows how to calculate it. Use a solar proposal tool to compare ownership, PPA and lease structures side by side, with incentives, demand-charge savings and rate escalation built in.

Compare ownership, PPA and lease cases

Run the same pharmaceutical site through cash, loan and third-party structures with your own tariff and incentives.

Book a Demo

Want plan details? See the SurgePV pricing page · No commitment required


Common Pharmaceutical Solar Design Mistakes

Pharmaceutical solar projects fail or underperform for predictable reasons. Here are the most common design mistakes and how to avoid them.

1. Sizing by roof area instead of verified HVAC load

A large roof can fit a big array, but a big array that exports most of its production at avoided-cost rates loses money. Start with interval data and target high self-consumption.

2. Ignoring demand charges and time-of-use rates

Annual kWh offset is the wrong metric if the facility pays steep demand charges. Model the hourly bill, including peak windows, to size the array and battery correctly.

3. Using inverters with high harmonic distortion

Inverter harmonics can interfere with cleanroom VFDs, lab instruments and process controls. Get harmonic data from the datasheet, check the applicable standard and validate with a power-quality study.

4. Treating the battery as a backup replacement

A battery improves economics and resilience, but it does not replace a generator for long-duration outages. Size backup power separately.

5. Skipping structural and membrane review

Pharmaceutical roofs often sit above validated cleanrooms. Adding ballasted solar without a structural review can overload the building. A leaky membrane raises the HVAC load and can compromise cleanroom classification.

6. Forgetting GMP change control

The electrical change must be documented in the facility’s change-control register. Without updated single-line diagrams, FAT/SAT records and staff training, the project creates audit risk even if it performs well technically.

7. Poor interconnection and export assumptions

Export limits, net metering caps and utility study timelines can derail a project. Submit a pre-application early and model the export value realistically.


Worked Example: 50,000 sq ft Oral Solid Dose Facility

Here is a sizing exercise for a 50,000 square foot oral solid dose facility in Houston, Texas. This is an illustrative design example, not a real project and not market data. Replace every assumption with the plant’s own data.

Assumptions:

  • Annual electricity use: 3,000,000 kWh (assumption)
  • Peak demand: 1,200 kW; HVAC baseload: 450 kW (assumptions)
  • Electricity rate: $0.12 per kWh (assumption)
  • Cost: $1.55 per Wdc (NLR Q1 2024 commercial benchmark; a real quote will differ)
  • Production: NLR PVWatts v8 run for Houston, south-facing, 10 degree tilt, 14 percent losses

Sizing target:

The design targets a 35 percent annual offset to keep self-consumption high: 3,000,000 × 0.35 = 1,050,000 kWh a year. At a 15.7 percent capacity factor, that needs about 763 kWp. Round to 750 kWdc, which PVWatts puts at about 1,034,600 kWh a year.

Line Calculation Value
Cost before incentives 750,000 W × $1.55 $1,162,500
30% federal credit, if the project qualifies 30% × $1,162,500 $348,750
Net cost $813,750
Year-1 energy savings 1,034,600 kWh × $0.12 about $124,150
Simple payback with the credit 813,750 ÷ 124,150 about 6.6 years
Simple payback without the credit 1,162,500 ÷ 124,150 about 9.4 years

This assumes the HVAC and process load absorbs nearly all output, which an 8,760-hour simulation must confirm. It excludes demand-charge savings, which solar alone may not deliver because peaks can occur after sunset. As arithmetic only, a battery that reliably shaved 250 kW at an assumed $15 per kW per month would add $45,000 a year, before the battery’s own cost. The paybacks also ignore degradation, rate changes, operating cost, financing and depreciation.

Simple payback in the worked example (illustrative example, not market data) (years)
  • With 30% credit6.6 yrs
  • Without credit9.4 yrs

Source: worked example in this guide: NLR benchmark cost, PVWatts production, assumed $0.12 per kWh, checked 4 November 2026.

If net metering pays only avoided-cost rates for exports, reduce the array size or add storage to lift self-consumption.


Next Steps for Your Pharmaceutical Solar Project

Pharmaceutical solar can fit well because the cleanroom load is large and steady. The projects that succeed treat the facility as a 24/7 validated process load. They size the array for self-consumption, protect power quality, and coordinate every electrical change through GMP change control.

Three actions will move you forward today:

  1. Pull 12 to 24 months of interval data and benchmark the facility against its own history. Identify whether the roof, carport or ground-mount path has the most buildable area.

  2. Run a tariff-first design in solar design software. Model production hour by hour, then test three sizing scenarios against demand charges, export rules and cleanroom baseload before finalising the kWp number.

  3. Compare ownership, PPA and lease structures using a solar proposal tool that handles tax credits, depreciation and pharmaceutical cash flow. If you want a live walkthrough, book a SurgePV demo.


Frequently Asked Questions

What is solar design for a pharmaceutical facility?

It is the process of sizing, laying out and integrating a photovoltaic system to offset a drug manufacturing plant’s electricity use. It starts with the cleanroom HVAC load curve, models solar output against validated process loads, and selects mounting, inverter and backup options that do not compromise GMP compliance.

How much electricity does a pharmaceutical facility use?

It varies widely, so use the plant’s own meter data. A 2008 LBNL guide for EPA ENERGY STAR estimated HVAC at about 65 percent of energy use in the pharmaceutical industry. An industry article puts HVAC at 50 to 80 percent of site energy in pharma, life science and hi-tech sectors.

How do you size a solar array for a pharmaceutical facility?

Collect 12 to 24 months of interval data, separate cleanroom HVAC baseload from process peaks, and target an offset that keeps most output on site. Divide target annual kWh by capacity factor and 8,760 hours. For example, 1,050,000 kWh at a 15.7 percent capacity factor needs about 760 kWdc.

Which mounting option is best for pharmaceutical solar?

Rooftop is usually best when the roof has adequate structural capacity and remaining life. Carports suit old or small roofs, and ground-mount suits campuses with spare land. Over cleanroom roofs, ask the roofing contractor and structural engineer whether non-penetrating ballasted mounting protects the membrane.

Should pharmaceutical solar include battery storage?

It can, when the facility pays high demand charges or values resilience for critical loads. A battery shifts midday surplus to evening peaks and can cover brief outages. It does not replace the on-site generator needed for long-duration backup, so model the plant with and without it.

Can solar power run a pharmaceutical facility during a grid outage?

Not on its own. A grid-tied array shuts down during a utility outage, and output stops at night. A solar-plus-storage system with a microgrid controller can carry selected loads for a limited time, but most plants keep generators for extended outages and redundancy requirements.

What incentives are available for pharmaceutical solar in 2026?

The IRS describes a clean electricity investment credit of up to 30 percent for facilities that meet prevailing wage and apprenticeship rules, and IRS Notice 2025-42 sets deadlines for solar. Depreciation rules changed in 2025, so use a tax adviser’s current schedule. State and utility programs vary, so check DSIRE.

Where this fits

This article is part of SurgePV's Solar Design hub, which works through the topic from first principles to the decisions a project team actually has to make.

About the Contributors

Author
Nirav Dhanani
Nirav Dhanani

Co-Founder · SurgePV

Nirav Dhanani is identified by SurgePV as a company co-founder. His SurgePV author page lists only role information that can be tied to the public profile below; credentials, project totals, conversion results, and market-expansion claims are not asserted without retained evidence.

Editor
Rainer Neumann
Rainer Neumann

Editorial contributor · SurgePV

Rainer Neumann is credited as an editorial contributor on SurgePV content. This profile does not assert engineering credentials, project totals, software-testing experience, education, speaking engagements, or media citations because independent verification evidence is not retained in the publication record.

Get Solar Design Tips in Your Inbox

Join 2,000+ solar professionals. One email per week - no spam.

No spam · Unsubscribe anytime

Book Free Demo

Choose which optional technologies SurgePV may use. Essential storage remains active for security and requested features.